Table 3.
Incident Opportunistic Infections on HAART
| |
0-3 months on HAART n (% of 106) |
4-6 months on HAART n (% of 106) |
> 6 months on HAART n (% of 106) |
Total n (% of 106) |
|---|---|---|---|---|
| Herpes Zoster (VZV) |
9 (8.5) |
18 (17) |
13 (12.3) |
40 (37.7) |
| Pulmonary TB |
11 (10.4) |
19 (17.9) |
6 (5.7) |
36 (34) |
| Extra-pulmonary TB |
2 (1.9) |
2 (1.9) |
9 (8.5) |
13 12.3) |
| Malignancies | ||||
| Kaposi's sarcoma | 2 (1.9) | 0 | 0 | 2 (1.9) |
| Invasive cervical carcinoma | 1 (.9) | 1 (0.9) | 1 (0.9) | 3 (2.8) |
| Squamous cell penile carcinoma | 0 | 0 | 1 | 1 (0.0) |
| Non-Hodgkin's lymphoma |
0 |
1 (0.9) |
0 |
1 (0.9) |
| Cryptococcal Meningitis |
1 (0.9) |
3 (2.8) |
0 |
4 (3.8) |
|
Pneumocystis jiroveci (carinii) pneumonia |
1 (0.9) |
2 (1.9) |
0 |
3 (2.8) |
| Esophageal candidiasis |
0 |
2 (1.9) |
0 |
2(1.9) |
|
Cytomegalovirus (CMV) Retinitis |
0 |
0 |
1 (0.9) |
1 (0.9) |
| Total | 27 (25.5) | 48 (45.3) | 31 (29.2) | 106 (100) |